Add-on Acquisition • Medical Products

Watson Pharmaceuticals Acquires Pharmaco Hf.

On October 31, 2012, Watson Pharmaceuticals acquired medical products company Pharmaco Hf. for 4.3B EUR

Acquisition Context

This is Watson Pharmaceuticals’ 3rd transaction in the Medical Products sector.
This is Watson Pharmaceuticals’ 0th largest (disclosed) transaction.
This is Watson Pharmaceuticals’ 1st transaction in Iceland.

Explore All 2731 Add-on Acquisition Medical Products Deals - Search the Database Free

M&A Deal Summary
Date	October 31, 2012
Target	Pharmaco Hf.
Sector	Medical Products
Buyer(s)	Watson Pharmaceuticals
Deal Type	Add-on Acquisition
Deal Value	4.3B EUR

Target Company

Pharmaco Hf.

Hafnarfirdi,, Iceland

Pharmaco Hf. engages in the development, manufacture, and sale of generic pharmaceuticals.

Explore More Deals

Browse All 215,130 Deals

FILTER BY

Buyer Type (PE or Strategic)
Deal Size ($10M to $10B+)
Sector (60 Sectors)
Deal Type
Geography
& More

Search Free

Buyer Overview 1

Buyer

Watson Pharmaceuticals

Florham Park, New Jersey, United States

Category	Company
Founded	1931
Sector	Medical Products
Employees	1,325

DESCRIPTION

Watson Pharmaceuticals, Inc.,is a specialty pharmaceutical company that develops, manufactures, markets and distributes branded and generic pharmaceutical products. Watson pursues a growth strategy combining internal product development, strategic alliances and collaborations and synergistic acquisitions of products and businesses.

Deal Context for Buyer	#
Overall	8 of 9
Sector: Medical Products	3 of 4
Type: Add-on Acquisition	4 of 5
Country: Iceland	1 of 1
Year: 2012	2 of 2

PREVIOUS DEAL

DATE	TARGET	DEAL TYPE	VALUE
2012-01-24	Ascent Pharmahealth Melbourne, Australia Ascent Pharmahealth Ltd, markets in Australia, Singapore, Malaysia, Hong Kong, Vietnam, Thailand and other Asian countries with a range of generic pharmaceuticals, consumer skincare and over the-counter (OTC) medicines. Ascent has a regional manufacturing facility located in Singapore which manufactures prescription and OTC products in varied dosage forms for the Southeast Asia market.	Buy	AU$375M

DATE

TARGET

DEAL TYPE

VALUE

2012-01-24

Ascent Pharmahealth

Melbourne, Australia

Ascent Pharmahealth Ltd, markets in Australia, Singapore, Malaysia, Hong Kong, Vietnam, Thailand and other Asian countries with a range of generic pharmaceuticals, consumer skincare and over the-counter (OTC) medicines. Ascent has a regional manufacturing facility located in Singapore which manufactures prescription and OTC products in varied dosage forms for the Southeast Asia market.

Buy

AU$375M

FOLLOWING DEAL

DATE	TARGET	DEAL TYPE	VALUE
2013-01-23	Uteron Pharma SA Grâce-Hollogne, Belgium Uteron Pharma SA is a development-based company dedicated to female healthcare. Uteron has a diversified portfolio of innovative products in different stages of development. The product development portfolio includes a hormonal IUD, a next generation oral contraceptives containing natural estrogen, a new generation of biochemical tests that will significantly increase in-vitro fertilization success rates, and pharmacologic treatments for cervical dysplasia.	Buy	$150M

DATE

TARGET

DEAL TYPE

VALUE

2013-01-23

Uteron Pharma SA

Grâce-Hollogne, Belgium

Uteron Pharma SA is a development-based company dedicated to female healthcare. Uteron has a diversified portfolio of innovative products in different stages of development. The product development portfolio includes a hormonal IUD, a next generation oral contraceptives containing natural estrogen, a new generation of biochemical tests that will significantly increase in-vitro fertilization success rates, and pharmacologic treatments for cervical dysplasia.

Buy

$150M

Explore Related M&A Activity

Medical Products M&A - Add-on Acquisition M&A Deals - Iceland M&A - 2012 M&A